Skip to main content
Erschienen in: Journal of Neurology 9/2012

01.09.2012 | Original Communication

Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients

verfasst von: Roberto Erro, Gabriella Santangelo, Marina Picillo, Carmine Vitale, Marianna Amboni, Katia Longo, Angela Costagliola, Maria Teresa Pellecchia, Roberto Allocca, Anna De Rosa, Giuseppe De Michele, Lucio Santoro, Paolo Barone

Erschienen in: Journal of Neurology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Little is known about the relationship between cognitive dysfunctions and the non-motor complex in subjects with newly diagnosed untreated Parkinson’s disease (PD). The aim of this study was to explore the association between non-motor symptoms (NMS) and cognitive dysfunctions in an incident cohort of de novo, drug-naive, PD patients. Sixty-six non-demented, early, untreated PD patients completed a semi-structured interview on NMS and a battery of neuropsychological tests that assess verbal memory, visuospatial abilities, and attention/executive functions. Scores were age- and education-corrected. Patients who failed at least two tests for each cognitive domain were diagnosed as having mild cognitive impairment (MCI). All but three (95.4%) PD patients complained of at least one NMS. A total of 37.8% was diagnosed with MCI. There was a relationship between sleep-NMS and cognitive dysfunctions. Specifically, both REM behavioral sleep disorders (RBD) and insomnia were associated with lower scores on several cognitive tests. Moreover, RBD was closely related to MCI. NMS and MCI are very common even in the early phase of PD, before patients are treated. Given the correlation between sleep disturbances and cognitive impairment, it is possible that sleep symptoms in PD patients might be considered as an early marker of dementia.
Literatur
1.
Zurück zum Zitat Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942PubMed Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942PubMed
2.
Zurück zum Zitat Findley L, Aujla M, Bain PG et al (2003) Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord 18:1139–1145PubMedCrossRef Findley L, Aujla M, Bain PG et al (2003) Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord 18:1139–1145PubMedCrossRef
3.
Zurück zum Zitat Shiba M, Bower JH, Maraganore DM et al (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 15:669–677PubMedCrossRef Shiba M, Bower JH, Maraganore DM et al (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 15:669–677PubMedCrossRef
4.
Zurück zum Zitat Claassen DO, Josephs KA, Ahlskog JE et al (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75(6):494–499PubMedCrossRef Claassen DO, Josephs KA, Ahlskog JE et al (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75(6):494–499PubMedCrossRef
5.
Zurück zum Zitat Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):S293–S298CrossRef Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):S293–S298CrossRef
6.
Zurück zum Zitat Pacchetti C, Manni R, Zangaglia R et al (2005) Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 20:1439–1448PubMedCrossRef Pacchetti C, Manni R, Zangaglia R et al (2005) Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 20:1439–1448PubMedCrossRef
7.
Zurück zum Zitat Kehagia AA, Barker RA, Robbins WR (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef Kehagia AA, Barker RA, Robbins WR (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef
8.
Zurück zum Zitat Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349PubMedCrossRef Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349PubMedCrossRef
9.
Zurück zum Zitat Aarsland D, Andersen K, Larsen JP et al (2001) Risk of dementia in Parkinson’s disease. Neurology 56:730–736PubMedCrossRef Aarsland D, Andersen K, Larsen JP et al (2001) Risk of dementia in Parkinson’s disease. Neurology 56:730–736PubMedCrossRef
10.
Zurück zum Zitat Santangelo G, Vitale C, Trojano L et al (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256(4):632–638PubMedCrossRef Santangelo G, Vitale C, Trojano L et al (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256(4):632–638PubMedCrossRef
11.
Zurück zum Zitat Pedersen KF, Alves G, Aarsland D et al (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80(11):1279–1282PubMedCrossRef Pedersen KF, Alves G, Aarsland D et al (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80(11):1279–1282PubMedCrossRef
12.
Zurück zum Zitat Santangelo G, Trojano L, Vitale C et al (2007) A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Mov Disord 22(16):2418–2425PubMedCrossRef Santangelo G, Trojano L, Vitale C et al (2007) A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Mov Disord 22(16):2418–2425PubMedCrossRef
13.
Zurück zum Zitat Marion MH, Qurashi M, Marshall G, Foster O (2008) Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson’s disease? J Neurol 255(2):192–196PubMedCrossRef Marion MH, Qurashi M, Marshall G, Foster O (2008) Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson’s disease? J Neurol 255(2):192–196PubMedCrossRef
14.
Zurück zum Zitat Kulisevsky J, Garcia-Sanchez C, Berthier ML et al (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626PubMedCrossRef Kulisevsky J, Garcia-Sanchez C, Berthier ML et al (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626PubMedCrossRef
15.
Zurück zum Zitat Fera F, Nicoletti G, Cerasa A et al (2007) Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson’s disease. Brain Res Bull 74:75–83PubMedCrossRef Fera F, Nicoletti G, Cerasa A et al (2007) Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson’s disease. Brain Res Bull 74:75–83PubMedCrossRef
16.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
17.
Zurück zum Zitat Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedCrossRef Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedCrossRef
18.
Zurück zum Zitat Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9PubMedCrossRef Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9PubMedCrossRef
19.
Zurück zum Zitat Lang AE, Riley DE, Bergeron C (1994) Cortical-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. WB Saunders, Philadelphia, pp 877–894 Lang AE, Riley DE, Bergeron C (1994) Cortical-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. WB Saunders, Philadelphia, pp 877–894
20.
Zurück zum Zitat McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124PubMedCrossRef McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124PubMedCrossRef
21.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRef
22.
Zurück zum Zitat Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Mardsen CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Florham Park N, Macmillan Healthcare Information, pp 153–163 Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Mardsen CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Florham Park N, Macmillan Healthcare Information, pp 153–163
23.
Zurück zum Zitat Chaudhuri KR, Martinez-Martin P, Schapira AHV et al (2006) An international multicentre pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923PubMedCrossRef Chaudhuri KR, Martinez-Martin P, Schapira AHV et al (2006) An international multicentre pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923PubMedCrossRef
24.
Zurück zum Zitat Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6(Suppl 8):8–20 Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6(Suppl 8):8–20
25.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental health disorders, 4th edn. Washington, DC American Psychiatric Association (1994) Diagnostic and statistical manual of mental health disorders, 4th edn. Washington, DC
26.
Zurück zum Zitat Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22(9):1272–1277PubMedCrossRef Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22(9):1272–1277PubMedCrossRef
27.
Zurück zum Zitat Chaudhuri KR, Naidu Y (2008) Early Parkinson’s disease and non-motor issues. J Neurol 255(suppl 5):33–38PubMedCrossRef Chaudhuri KR, Naidu Y (2008) Early Parkinson’s disease and non-motor issues. J Neurol 255(suppl 5):33–38PubMedCrossRef
28.
Zurück zum Zitat Dhawan V, Dhoat S, Williams AJ et al (2006) The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci 248:158–162PubMedCrossRef Dhawan V, Dhoat S, Williams AJ et al (2006) The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci 248:158–162PubMedCrossRef
29.
Zurück zum Zitat Müller B, Larsen JP, Wentzel-Larsen T et al (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26(1):65–72PubMedCrossRef Müller B, Larsen JP, Wentzel-Larsen T et al (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26(1):65–72PubMedCrossRef
30.
Zurück zum Zitat Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649PubMedCrossRef Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649PubMedCrossRef
31.
Zurück zum Zitat Iranzo A, Molinuevo JL, Santamaría J et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577PubMedCrossRef Iranzo A, Molinuevo JL, Santamaría J et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577PubMedCrossRef
32.
Zurück zum Zitat Aarsland D, Brønnick K, Larsen JP et al (2009) Cognitive impairment in incident untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72(13):1121–1126PubMedCrossRef Aarsland D, Brønnick K, Larsen JP et al (2009) Cognitive impairment in incident untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72(13):1121–1126PubMedCrossRef
33.
Zurück zum Zitat Foltynie T, Brayne CE, Robbins TW et al (2004) The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain 127(Pt 3):550–560PubMed Foltynie T, Brayne CE, Robbins TW et al (2004) The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain 127(Pt 3):550–560PubMed
34.
Zurück zum Zitat Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245PubMedCrossRef Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245PubMedCrossRef
35.
Zurück zum Zitat Aarsland D, Cummings JL, Larsen JP (2001) Neuropsychiatric differences between Parkinson’s disease with dementia and Alzheimer’s disease. Int J Geriatr Psychiatry 16:184–191PubMedCrossRef Aarsland D, Cummings JL, Larsen JP (2001) Neuropsychiatric differences between Parkinson’s disease with dementia and Alzheimer’s disease. Int J Geriatr Psychiatry 16:184–191PubMedCrossRef
36.
Zurück zum Zitat Bronnick K, Aarsland D, Larsen JP (2005) Neuropsychiatric disturbances in Parkinson’s disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand 112:201–207PubMedCrossRef Bronnick K, Aarsland D, Larsen JP (2005) Neuropsychiatric disturbances in Parkinson’s disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand 112:201–207PubMedCrossRef
37.
Zurück zum Zitat Naismith SL, Lewis SJG (2011) “DASH” symptoms in patients with Parkinson’s disease: red flags for early cognitive decline. J Clin Neurosci 18(3):352–355PubMedCrossRef Naismith SL, Lewis SJG (2011) “DASH” symptoms in patients with Parkinson’s disease: red flags for early cognitive decline. J Clin Neurosci 18(3):352–355PubMedCrossRef
38.
Zurück zum Zitat Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474PubMedCrossRef Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474PubMedCrossRef
39.
Zurück zum Zitat Perez-Lloret S, Rossi M, Cardinali DP, Merello M (2008) Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest). Parkinsonism Relat Disord 14(8):641–645PubMedCrossRef Perez-Lloret S, Rossi M, Cardinali DP, Merello M (2008) Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest). Parkinsonism Relat Disord 14(8):641–645PubMedCrossRef
40.
Zurück zum Zitat Gagnon JF, Vendette M, Postuma RB et al (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47PubMedCrossRef Gagnon JF, Vendette M, Postuma RB et al (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47PubMedCrossRef
41.
Zurück zum Zitat Vendette M, Gagnon JF, Décary A et al (2007) REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 69(19):1843–1849PubMedCrossRef Vendette M, Gagnon JF, Décary A et al (2007) REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 69(19):1843–1849PubMedCrossRef
42.
43.
Zurück zum Zitat Braak H, Rüb U, Jansen Steur EN et al (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410PubMedCrossRef Braak H, Rüb U, Jansen Steur EN et al (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410PubMedCrossRef
44.
Zurück zum Zitat Emre M (2004) Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol 17(4):399–404PubMedCrossRef Emre M (2004) Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol 17(4):399–404PubMedCrossRef
Metadaten
Titel
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients
verfasst von
Roberto Erro
Gabriella Santangelo
Marina Picillo
Carmine Vitale
Marianna Amboni
Katia Longo
Angela Costagliola
Maria Teresa Pellecchia
Roberto Allocca
Anna De Rosa
Giuseppe De Michele
Lucio Santoro
Paolo Barone
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6407-0

Weitere Artikel der Ausgabe 9/2012

Journal of Neurology 9/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.